ID
20626
Beschrijving
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia.; ODM derived from: https://clinicaltrials.gov/show/NCT00532129
Link
https://clinicaltrials.gov/show/NCT00532129
Trefwoorden
Versies (1)
- 07-03-17 07-03-17 -
Geüploaded op
7 maart 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lymphocytic Leukemia, Chronic NCT00532129
Eligibility Lymphocytic Leukemia, Chronic NCT00532129
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
previous treatment for cll
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0023434
Beschrijving
concomitant hematological malignancy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0243087
- UMLS CUI [1,2]
- C0376545
Beschrijving
transformation to aggressive b-cell malignancy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3149729
- UMLS CUI [1,2]
- C0023434
Beschrijving
history of severe cardiac disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0018799
- UMLS CUI [1,3]
- C0205082
Beschrijving
hypersensitivity murine antibodies
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C2916903
Similar models
Eligibility Lymphocytic Leukemia, Chronic NCT00532129
- StudyEvent: Eligibility
C3888518 (UMLS CUI [1,2])
C0332155 (UMLS CUI [2])
C0332121 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0023434 (UMLS CUI [1,2])
C0376545 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C2916903 (UMLS CUI [1,2])